Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 05-2011 | 03-2011 | |
Operating Expenses | 1,420 | 1,140 | 0 | 0 | 1,580 |
Operating Income | -1,420 | -1,140 | N/A | N/A | -1,580 |
Other Income | -10 | -10 | 0 | 0 | 0 |
Pre-tax Income | -1,430 | -1,150 | 0 | 0 | -1,580 |
Net Income Continuous | -1,429 | -1,100 | -1,052 | N/A | -1,586 |
Net Income | $-1,429 | $-1,100 | $-1,052 | $N/A | $-1,586 |
EPS Basic Total Ops | -12.60 | -10.80 | -10.80 | N/A | -18.00 |
EPS Basic Continuous Ops | -12.15 | -11.31 | -10.96 | N/A | -18.21 |
EPS Diluted Total Ops | -12.60 | -10.80 | -10.80 | N/A | -18.00 |
EPS Diluted Continuous Ops | -12.15 | -11.31 | -10.96 | N/A | -18.21 |
EBITDA(a) | $-1,410 | $-1,180 | $10 | $N/A | $-1,540 |